Skip to search formSkip to main contentSkip to account menu

NY 198

Known as: NY-198 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
The effect of a newly developed quinolone, NY-198, on the pharmacokinetics and metabolism of theophylline was investigated under… 
Highly Cited
1988
Highly Cited
1988
Lomefloxacin (SC-47111; NY-198) is a new difluoroquinolone agent. It inhibited 90% of Escherichia coli, Klebsiella spp… 
Highly Cited
1988
Highly Cited
1988
The specific binding of 3H-labeled gamma-aminobutyric acid ([3H]GABA) to synaptic plasma membranes from rat brains was inhibited… 
1988
1988
Comparative physiological pharmacokinetic analysis has been carried out to elucidate the different tissue distribution… 
Highly Cited
1988
Highly Cited
1988
DR-3355, the S-(-)-isomer of ofloxacin, was generally twice as potent as ofloxacin against a variety of gram-positive and gram… 
Highly Cited
1988
Highly Cited
1988
The in vitro activity of lomefloxacin (SC-47111; NY-198), a new difluorinated quinolone, was compared with those of ofloxacin… 
1988
1988
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10… 
1988
1988
The present study describes quantitatively the pharmacokinetics of the antibacterial agents, ofloxacin and NY-198… 
Highly Cited
1987
Highly Cited
1987
NY-198 [1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3- quinolinecarboxylic acid hydrochloride] is a new…